CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
VERAXA Biotech
VERAXA Biotech

VERAXA Biotech

VERAXA Biotech develops engineered antibody therapies and conjugates for cancer.

Operating headquarters
Heidelberg, Baden-Württemberg, DE🇩🇪
Founded
2021
Overview
Compare
Employees
Library

VERAXA Biotech develops antibody-based cancer therapeutics through its ADC and BiTAC technology platforms. Its first-party science pages describe site-specific antibody conjugation, payload chemistry, and conditionally activated bispecific formats intended to distinguish tumor from healthy tissue.

The company also applies functional antibody screening to discover candidate molecules. Its BiTAC platform encompasses T-cell engager and antibody-drug conjugate designs, while its ADC technology controls conjugation sites and payload placement. The reported programs are in development; the platform descriptions do not establish clinical efficacy or approval.

VERAXA Biotech - Similar Companies

Verax Biomedical logo

Verax Biomedical

BioNTech logo

BioNTech

biontech.com

Veralox Therapeutics logo

Veralox Therapeutics

veralox.com

Verax Research Services logo

Verax Research Services

veraxresearch.com

Angiex logo

Angiex

angiex.com

Valink Therapeutics logo

Valink Therapeutics

valinktx.com

Veru logo

Veru

verupharma.com

Tavotek Biotherapeutics logo

Tavotek Biotherapeutics

tavotek.com

Ancora Biotech logo

Ancora Biotech

ancorabiotech.com

Avaxia Biologics logo

Avaxia Biologics

Veranex logo

Veranex

veranex.com

LiliumX logo

LiliumX

liliumx.com

Soteria Biotherapeutics logo

Soteria Biotherapeutics

Verda Bio logo

Verda Bio

verdabio.com

Hexagon Bio logo

Hexagon Bio

hexagonbio.com

VERAXA Biotech - Quick Facts

Who are VERAXA Biotech's competitors?

Companies similar to VERAXA Biotech include Verax Biomedical, BioNTech, Veralox Therapeutics and Verax Research Services.

When was VERAXA Biotech founded?

VERAXA Biotech was founded in 2021.

Where is VERAXA Biotech's headquarters located?

VERAXA Biotech's headquarters is located in Heidelberg, Baden-Württemberg, DE.

VERAXA Biotech - Classification

Tags
  • Biotechnology